Protection against lethal challenge of BALB/c mice by passive transfer of monoclonal antibodies to five glycoproteins of herpes simplex virus type 2 - PubMed (original) (raw)
Protection against lethal challenge of BALB/c mice by passive transfer of monoclonal antibodies to five glycoproteins of herpes simplex virus type 2
N Balachandran et al. Infect Immun. 1982 Sep.
Abstract
Monoclonal antibodies secreted by six hybridomas and recognizing antigenic sites on glycoproteins gC, gAB, gD, gE, and gF of herpes simplex virus type 2 were examined for their ability to protect BALB/c mice from lethal infection by the virus. Administration of monoclonal antibodies to individual glycoproteins intraperitoneally 3 h before footpad challenge with 10 times the 50% lethal dose of virus protected between 35 and 75% of the mice, except for one of two monoclonal antibodies recognizing antigens on gC. The antibodies did not neutralize virus in vitro and protected A/J mice deficient in the fifth component of complement as efficiently as complement-sufficient BALB/c mice. A good correlation was found between protection and titers of monoclonal antibodies assessed by antibody-dependent cell-mediated cytolysis. The results indicate that any of the glycoproteins can serve as antigens for a protective immune response. In addition, the data are compatible with protection being mediated by an antibody-dependent cell-mediated cytolysis mechanism.
Similar articles
- Purification of herpes simplex virus glycoproteins B and C using monoclonal antibodies and their ability to protect mice against lethal challenge.
Roberts PL, Duncan BE, Raybould TJ, Watson DH. Roberts PL, et al. J Gen Virol. 1985 May;66 ( Pt 5):1073-85. doi: 10.1099/0022-1317-66-5-1073. J Gen Virol. 1985. PMID: 2582080 - Helper T cells induced by an immunopurified herpes simplex virus type I (HSV-I) 115 kilodalton glycoprotein (gB) protect mice against HSV-I infection.
Chan WL, Lukig ML, Liew FY. Chan WL, et al. J Exp Med. 1985 Oct 1;162(4):1304-18. doi: 10.1084/jem.162.4.1304. J Exp Med. 1985. PMID: 2995536 Free PMC article. - Use of monoclonal antibody directed against herpes simplex virus glycoproteins to protect mice against acute virus-induced neurological disease.
Dix RD, Pereira L, Baringer JR. Dix RD, et al. Infect Immun. 1981 Oct;34(1):192-9. doi: 10.1128/iai.34.1.192-199.1981. Infect Immun. 1981. PMID: 6271681 Free PMC article. - The mouse model and understanding immunity to herpes simplex virus.
Mester JC, Rouse BT. Mester JC, et al. Rev Infect Dis. 1991 Nov-Dec;13 Suppl 11:S935-45. doi: 10.1093/clind/13.supplement_11.s935. Rev Infect Dis. 1991. PMID: 1664131 Review. - Herpes simplex virus antigens and antibodies: a survey of studies based on quantitative immunoelectrophoresis.
Vestergaard BF. Vestergaard BF. Rev Infect Dis. 1980 Nov-Dec;2(6):899-913. doi: 10.1093/clinids/2.6.899. Rev Infect Dis. 1980. PMID: 6164087 Review.
Cited by
- Human Antibodies against Herpes Simplex Virus 2 Glycoprotein G Do Not Neutralize but Mediate Antibody-Dependent Cellular Cytotoxicity.
Liljeqvist JÅ, Önnheim K, Tunbäck P, Eriksson K, Görander S, Bäckström M, Bergström T. Liljeqvist JÅ, et al. Antibodies (Basel). 2024 May 11;13(2):40. doi: 10.3390/antib13020040. Antibodies (Basel). 2024. PMID: 38804308 Free PMC article. - Effector functions are required for broad and potent protection of neonatal mice with antibodies targeting HSV glycoprotein D.
Slein MD, Backes IM, Garland CR, Kelkar NS, Leib DA, Ackerman ME. Slein MD, et al. Cell Rep Med. 2024 Feb 20;5(2):101417. doi: 10.1016/j.xcrm.2024.101417. Epub 2024 Feb 12. Cell Rep Med. 2024. PMID: 38350452 Free PMC article. - Protective mechanisms of nonneutralizing antiviral antibodies.
Chandler TL, Yang A, Otero CE, Permar SR, Caddy SL. Chandler TL, et al. PLoS Pathog. 2023 Oct 5;19(10):e1011670. doi: 10.1371/journal.ppat.1011670. eCollection 2023 Oct. PLoS Pathog. 2023. PMID: 37796829 Free PMC article. Review. - Monoclonal antibody therapy of herpes simplex virus: An opportunity to decrease congenital and perinatal infections.
Backes IM, Leib DA, Ackerman ME. Backes IM, et al. Front Immunol. 2022 Aug 9;13:959603. doi: 10.3389/fimmu.2022.959603. eCollection 2022. Front Immunol. 2022. PMID: 36016956 Free PMC article. Review. - Inducing broad-based immunity against viruses with pandemic potential.
Sette A, Saphire EO. Sette A, et al. Immunity. 2022 May 10;55(5):738-748. doi: 10.1016/j.immuni.2022.04.010. Immunity. 2022. PMID: 35545026 Free PMC article. Review.
References
- J Exp Med. 1967 Jan 1;125(1):1-16 - PubMed
- Acta Neuropathol. 1971;17(1):44-53 - PubMed
- Infect Immun. 1973 Feb;7(2):272-88 - PubMed
- Nature. 1974 Sep 27;251(5473):350-2 - PubMed
- Intervirology. 1974;3(1-2):1-14 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous